You are here: Industry Insights > Market News > Chinese mainland reports 54 locally transmitted COVID-19 cases

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

98% Bifida Ferment Lysate

rhSOD (cosmetic grade)

Recombinant humanized collagen

Recombinant Humanized Small-molecule Collagen

Recombinant Humanized Small-molecule Collagen Solution

rhSOD

Chinese mainland reports 54 locally transmitted COVID-19 cases

NMPANovember 03, 2021

Tag: COVID-19 , mainland , Beijing

Favorites

BEIJING -- The Chinese mainland on Monday reported 54 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 2.

Of the new local cases, 27 were reported in Heilongjiang, eight in Hebei, another eight in Gansu, three in Shandong, two each in Inner Mongolia, Jiangxi and Qinghai, and one each in Beijing and Ningxia, the commission said.

Monday also saw 17 new imported cases, including four previously reported asymptomatic carriers, it said.

Two new suspected cases arriving from outside the mainland were reported in Shanghai and no new deaths from COVID-19 were reported on Monday, it added.

Previous:Brilli Launches New Bright Clean 24" Led Vanity Bar Exclusively with Home Depot and Discovers New Efficacy Against Covid-19

Next:BioMed X Institute Successfully Completes Fourth Project in Oncology in Collaboration with Merck KGaA, Darmstadt, Germany

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Chinese mainland reports 54 locally transmitted COVID-19 cases | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

Chinese mainland reports 54 locally transmitted COVID-19 cases

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

You may like
More>>

Chinese mainland reports 54 locally transmitted COVID-19 cases

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

You may likeMore>>

You may like
More>>